Alpine Associates Management Inc. Acquires 27,403 Shares of Amedisys, Inc. (NASDAQ:AMED)

Alpine Associates Management Inc. raised its stake in shares of Amedisys, Inc. (NASDAQ:AMED) by 3.2% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 888,120 shares of the health services provider’s stock after acquiring an additional 27,403 shares during the quarter. Amedisys comprises 4.9% of Alpine Associates Management Inc.’s portfolio, making the stock its 7th biggest holding. Alpine Associates Management Inc.’s holdings in Amedisys were worth $80,632,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently made changes to their positions in the company. Blue Trust Inc. lifted its holdings in Amedisys by 55.1% in the 4th quarter. Blue Trust Inc. now owns 349 shares of the health services provider’s stock worth $34,000 after purchasing an additional 124 shares during the last quarter. HBW Advisory Services LLC acquired a new stake in shares of Amedisys in the fourth quarter worth $38,000. Versant Capital Management Inc boosted its holdings in shares of Amedisys by 68.5% during the 4th quarter. Versant Capital Management Inc now owns 450 shares of the health services provider’s stock worth $41,000 after buying an additional 183 shares during the period. KBC Group NV acquired a new position in Amedisys in the 3rd quarter valued at $63,000. Finally, Venturi Wealth Management LLC grew its stake in Amedisys by 397.4% in the 4th quarter. Venturi Wealth Management LLC now owns 975 shares of the health services provider’s stock valued at $89,000 after buying an additional 779 shares during the last quarter. Institutional investors and hedge funds own 94.36% of the company’s stock.

Amedisys Price Performance

NASDAQ:AMED opened at $92.37 on Friday. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.19 and a quick ratio of 1.19. The stock has a market cap of $3.03 billion, a P/E ratio of 36.65, a PEG ratio of 1.78 and a beta of 0.76. The company has a fifty day moving average price of $92.00 and a 200 day moving average price of $92.97. Amedisys, Inc. has a one year low of $82.15 and a one year high of $98.95.

Amedisys (NASDAQ:AMED) last released its earnings results on Wednesday, February 26th. The health services provider reported $0.96 earnings per share for the quarter, missing analysts’ consensus estimates of $1.05 by ($0.09). The firm had revenue of $598.05 million for the quarter, compared to analyst estimates of $602.38 million. Amedisys had a return on equity of 12.20% and a net margin of 3.57%. Analysts anticipate that Amedisys, Inc. will post 4.4 earnings per share for the current year.

Analyst Ratings Changes

Separately, Stephens restated an “equal weight” rating and set a $101.00 price target on shares of Amedisys in a report on Tuesday, March 4th. Five equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $100.75.

Amedisys Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.